[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Venom duct;
DOI=10.1074/jbc.M309654200; PubMed=14701840 [NCBI, ExPASy, EBI, Israel, Japan]
Santos A.D.,
McIntosh J.M.,
Hillyard D.R.,
Cruz L.J.,
Olivera B.M.;
"The A-superfamily of conotoxins: structural and functional divergence.";
J. Biol. Chem. 279:17596-17606(2004).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-68.
TISSUE=Hepatopancreas;
DOI=10.1074/jbc.M205102200; PubMed=12114524 [NCBI, ExPASy, EBI, Israel, Japan]
McIntosh J.M.,
Dowell C.,
Watkins M.,
Garrett J.E.,
Yoshikami D.,
Olivera B.M.;
"Alpha-conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors.";
J. Biol. Chem. 277:33610-33615(2002).
|
[3]
|
PROTEIN SEQUENCE OF 49-64, SYNTHESIS OF 49-64, AMIDATION AT CYS-64, DISULFIDE BONDS, MASS SPECTROMETRY, AND FUNCTION.
TISSUE=Venom;
DOI=10.1074/jbc.271.13.7522; PubMed=8631783 [NCBI, ExPASy, EBI, Israel, Japan]
Cartier G.E.,
Yoshikami D.,
Gray W.R.,
Luo S.,
Olivera B.M.,
McIntosh J.M.;
"A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.";
J. Biol. Chem. 271:7522-7528(1996).
|
[4]
|
FUNCTION ON ALPHA-6 ACHR.
DOI=10.1016/S0028-3908(00)00144-1; PubMed=11044728 [NCBI, ExPASy, EBI, Israel, Japan]
Kuryatov A.,
Olale F.,
Cooper J.,
Choi C.,
Lindstrom J.;
"Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.";
Neuropharmacology 39:2570-2590(2000).
|
[5]
|
STRUCTURE BY NMR OF 49-64, AND DISULFIDE BONDS.
DOI=10.1021/bi971443r; PubMed=9398298 [NCBI, ExPASy, EBI, Israel, Japan]
Shon K.-J.,
Koerber S.C.,
Rivier J.E.,
Olivera B.M.,
McIntosh J.M.;
"Three-dimensional solution structure of alpha-conotoxin MII, an alpha3beta2 neuronal nicotinic acetylcholine receptor-targeted ligand.";
Biochemistry 36:15693-15700(1997).
|
[6]
|
STRUCTURE BY NMR OF 49-64, AMIDATION AT CYS-64, AND DISULFIDE BONDS.
DOI=10.1021/bi981535w; PubMed=9843366 [NCBI, ExPASy, EBI, Israel, Japan]
Hill J.M.,
Oomen C.J.,
Miranda L.P.,
Bingham J.-P.,
Alewood P.F.,
Craik D.J.;
"Three-dimensional solution structure of alpha-conotoxin MII by NMR spectroscopy: effects of solution environment on helicity.";
Biochemistry 37:15621-15630(1998).
|
[7]
|
CYCLIZATION, STRUCTURE BY NMR OF 49-64, AND DISULFIDE BONDS.
DOI=10.1073/pnas.0504613102; PubMed=16162671 [NCBI, ExPASy, EBI, Israel, Japan]
Clark R.J.,
Fischer H.,
Dempster L.,
Daly N.L.,
Rosengren K.J.,
Nevin S.T.,
Meunier F.A.,
Adams D.J.,
Craik D.J.;
"Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.";
Proc. Natl. Acad. Sci. U.S.A. 102:13767-13772(2005).
|
[8]
|
MUTAGENESIS OF ASN-53; PRO-54; HIS-57; HIS-60 AND LEU-63.
DOI=10.1021/bi036180h; PubMed=15005608 [NCBI, ExPASy, EBI, Israel, Japan]
Everhart D.,
Cartier G.E.,
Malhotra A.,
Gomes A.V.,
McIntosh J.M.,
Luetje C.W.;
"Determinants of potency on alpha-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors.";
Biochemistry 43:2732-2737(2004).
|
|